PE20040678A1 - Moduladores de los receptores selectivos de estrogenos - Google Patents

Moduladores de los receptores selectivos de estrogenos

Info

Publication number
PE20040678A1
PE20040678A1 PE2003000717A PE2003000717A PE20040678A1 PE 20040678 A1 PE20040678 A1 PE 20040678A1 PE 2003000717 A PE2003000717 A PE 2003000717A PE 2003000717 A PE2003000717 A PE 2003000717A PE 20040678 A1 PE20040678 A1 PE 20040678A1
Authority
PE
Peru
Prior art keywords
selective estrogen
modulators
estrogen receptors
leiomyomata
useful
Prior art date
Application number
PE2003000717A
Other languages
English (en)
Inventor
Kin Chiu Fong
Conrad Wilson Hummel
Robert Dean Dally
Scott Alan Jones
Timothy Alan Shepherd
George Sal Lewis
Owen Brendan Wallace
Scott Alan Frank
Jeffrey Alan Dodge
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PE20040678A1 publication Critical patent/PE20040678A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/64—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/72—Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA I DONDE m, q Y r SON CADA UNO 0-2; n ES 0-1; R ES H O COR2; R0 ES OH, CF3, HALO, ALQUILO C1-C6, ALCOXI C1-C6; R1 Y R1' SON CADA UNO ALQUILO C1-C6, CF3, CH2CF3, ENTRE OTROS; R2 ES ALQUILO C1-C6, ALCOXI C1-C6, FENOXI, ENTRE OTROS; X ES O, CH2, CO; X1 ES O, NH, N(ALQUILO C1-C6); R8 ES H O METILO SI r ES 1-2; Y ES S, CH2CH2, CH=CH. SON COMPUESTOS PREFERIDOS: 1-(2-{4-[2-(4-METANOSULFONIL-FENIL)-6-METOXI-NAFTALEN-1-ILOXI]-FENOXI}-ETIL)-PIPERIDINA; CLORHIDRATO DE 6-(4-METANOSULFONIL-FENIL)-5-[4-(2-PIPERIDIN-1-IL-ETOXI)-FENOXI]-NAFTALEN-2-IL ESTER DEL ACIDO 2,2-DIMETIL-PROPIONICO Y 5-[4-(2-PIPERIDIN-1-IL-ETOXI)FENOXI]-6-4-TRIFLUOROMETANOSULFONIL-FENIL)-NAFTALEN-2-OL. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DE LA ENDOMETRIOSIS UTERINA Y/O LEIOMIOMA/LEIOMIOMATA UTERINO
PE2003000717A 2002-07-22 2003-07-18 Moduladores de los receptores selectivos de estrogenos PE20040678A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39786902P 2002-07-22 2002-07-22
US45023303P 2003-02-25 2003-02-25

Publications (1)

Publication Number Publication Date
PE20040678A1 true PE20040678A1 (es) 2004-10-06

Family

ID=30773044

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2003000717A PE20040678A1 (es) 2002-07-22 2003-07-18 Moduladores de los receptores selectivos de estrogenos

Country Status (25)

Country Link
US (2) US7399867B2 (es)
EP (1) EP1530470B9 (es)
JP (2) JP4656939B2 (es)
CN (1) CN1668303B (es)
AT (1) ATE433322T1 (es)
AU (1) AU2003253129B2 (es)
BR (1) BR0312675A (es)
CA (1) CA2490580C (es)
CO (1) CO5680445A2 (es)
CR (1) CR7657A (es)
DE (1) DE60327931D1 (es)
EA (1) EA008024B1 (es)
EC (1) ECSP055549A (es)
ES (1) ES2326593T3 (es)
HK (1) HK1078003A1 (es)
HR (1) HRP20041233A2 (es)
IL (1) IL165745A0 (es)
MX (1) MXPA05000898A (es)
MY (1) MY141879A (es)
NO (1) NO20050832L (es)
NZ (1) NZ537138A (es)
PE (1) PE20040678A1 (es)
PL (1) PL374845A1 (es)
TW (1) TWI314860B (es)
WO (1) WO2004009086A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1530470B9 (en) * 2002-07-22 2010-04-07 Eli Lilly And Company Selective estrogen receptor modulators containing a phenylsulfonyl group
MXPA05009098A (es) * 2003-02-25 2005-11-17 Lilly Co Eli Clorhidrato de 1- (4-(2 -piperidiniletoxifenoxi) -2-(4-metansulfonilfenil) -6-hidroxinaftaleno cristalino no solvatado.
KR100693242B1 (ko) * 2003-02-25 2007-03-12 일라이 릴리 앤드 캄파니 결정성 비-용매화1-(4-(2-피페리디닐에톡시)페녹시)-2-(4-메탄술포닐페닐)-6-하이드록시나프탈렌 하이드로클로라이드
EP1709023B1 (en) * 2004-01-22 2009-11-11 Eli Lilly And Company Selective estrogen receptor modulators
CN1910167B (zh) * 2004-01-22 2011-08-10 伊莱利利公司 用于治疗血管舒缩症状的选择性雌激素受体调节剂
KR101008804B1 (ko) 2004-01-22 2011-01-14 일라이 릴리 앤드 캄파니 혈관운동 증상의 치료를 위한 선택적 에스트로겐 수용체조절제
EP1713770A1 (en) * 2004-01-29 2006-10-25 Eli Lilly And Company Selective estrogen receptor modulators
BRPI0512395A (pt) 2004-06-22 2008-03-11 Smithkline Beecham Corp composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou a profilaxia de condições ou distúrbios associadas(os) com a modulação de receptor de estrogênio seletiva, e para o tratamento ou a profilaxia relacionado(a) com condições ou distúrbios
CA2617146A1 (en) * 2005-07-29 2007-02-08 Eli Lilly And Company Crystalline non-solvated methanesulfonic acid salt of 1-(4-(2-piperidinylethoxy)phenoxy)-2-(3-hydroxyphenyl)-6-hydroxynaphthalene
CA2738878C (en) 2008-09-29 2013-08-13 Eli Lilly And Company Selective estrogen receptor modulator for the treatment of osteoarthritis
DE102008057230A1 (de) * 2008-11-11 2010-05-12 Bayer Schering Pharma Aktiengesellschaft Synergistische pharmazeutische Kombination mit einem Estrogenrezeptorantagonisten und einem Progestin
US20110319379A1 (en) 2009-03-11 2011-12-29 Corbett Jeffrey W Substituted Indazole Amides And Their Use As Glucokinase Activators
KR20170127044A (ko) 2010-06-16 2017-11-20 앙도르쉐르슈 인코포레이티드 에스트로겐-관련 질병의 치료 또는 예방 방법
JP6292744B2 (ja) * 2012-09-19 2018-03-14 富士カプセル株式会社 医薬品組成物
RS57106B1 (sr) 2013-02-19 2018-06-29 Novartis Ag Derivati benzotiofena i njihove kompozicije kao selektivni degraderi estrogenskog receptora
US20220167618A1 (en) 2019-03-08 2022-06-02 Syngenta Crop Protection Ag Pesticidally active azole-amide compounds
EP3941915A1 (en) 2019-03-20 2022-01-26 Syngenta Crop Protection AG Pesticidally active azole amide compounds
BR112021018822A2 (pt) 2019-03-22 2021-11-23 Syngenta Crop Protection Ag Derivados de n-[1-(5-bromo-2-pirimidin-2-il-1,2,4-triazol-3-il)etil]-2-ciclopropil-6-(trifluorometil)piridina-4-carboxamida e compostos relacionados como inseticidas
UY38623A (es) 2019-03-29 2020-10-30 Syngenta Crop Protection Ag Compuestos de diazina-amida activos como pesticidas
KR20210149113A (ko) 2019-04-05 2021-12-08 신젠타 크롭 프로텍션 아게 살충 활성 디아진-아미드 화합물
WO2021037614A1 (en) 2019-08-23 2021-03-04 Syngenta Crop Protection Ag Pesticidally active pyrazine-amide compounds
CN110526881B (zh) * 2019-08-27 2020-09-22 河南省锐达医药科技有限公司 一种萘胺类化合物及其生物学可接受的盐，其制备方法和应用
US20230143596A1 (en) 2020-02-27 2023-05-11 Syngenta Crop Protection Ag Pesticidally active diazine-bisamide compounds
WO2022237904A1 (zh) * 2021-05-14 2022-11-17 江苏亚虹医药科技股份有限公司 一种含萘环的化合物、含其的药物组合物及其应用
EP4352050A1 (en) 2021-06-09 2024-04-17 Syngenta Crop Protection AG Pesticidally active diazine-amide compounds
WO2023283315A1 (en) * 2021-07-07 2023-01-12 South Dakota Board Of Regents Compositions and methods for treatment of cervical and ovarian cancer
WO2024042187A1 (en) 2022-08-25 2024-02-29 Sanofi Novel substituted benzothiophene-6-carboxylic acid derivatives, processes for their preparation and therapeutic uses thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4418068A (en) 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
CA2135160A1 (en) 1992-05-08 1993-11-25 Masatoshi Inai Indole derivative
US6756388B1 (en) 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
US5484798A (en) 1994-09-20 1996-01-16 Eli Lilly And Company Benzothiopene compounds, compositions, and method of inhibiting restenosis
US7501441B1 (en) 1994-09-20 2009-03-10 Eli Lilly And Company Naphthyl compounds, intermediates, processes, compositions, and methods
US5552412A (en) 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
US5998401A (en) 1995-02-28 1999-12-07 Eli Lilly And Company Naphthyl compounds, intermediates, compositions, and methods
IL117276A (en) 1995-02-28 2001-10-31 Lilly Co Eli Benziophene compounds, their preparation and their related compositions
US5599822A (en) 1995-06-06 1997-02-04 Eli Lilly And Company Methods for minimizing bone loss
DE69634045T2 (de) * 1995-10-31 2005-05-19 Eli Lilly And Co., Indianapolis Antithrombotische diamine
EA000767B1 (ru) * 1996-02-22 2000-04-24 Эли Лилли Энд Компани Бензотиофены, составы, их содержащие, и способы с их использованием
NZ314601A (en) 1996-04-19 1999-09-29 American Home Prod 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole derivatives as estrogenic agents and pharmaceutical compositions
CA2214070C (en) 1996-08-29 2006-03-14 Eli Lilly And Company Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods
CA2213814A1 (en) 1996-08-29 1998-02-28 Henry Uhlman Bryant Naphthalene compounds, intermediates, formulations, and methods
CA2213810C (en) 1996-08-29 2006-06-06 Lewis Dale Pennington Benzo¬b|thiophene compounds, intermediates, processes, compositions and methods
ID19392A (id) 1996-08-29 1998-07-09 Lilly Co Eli Senyawa naftil dan bahan pertengahan serta komposisi dan metode penggunaan
CA2217810A1 (en) * 1996-10-10 1998-04-10 Eli Lilly And Company 2-aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods
CA2218756A1 (en) 1996-10-25 1998-04-25 Kristin Sue Marron Substituted benzo¢b!thiophene compounds having activity as selective estrogen receptor modulators
EP1530470B9 (en) * 2002-07-22 2010-04-07 Eli Lilly And Company Selective estrogen receptor modulators containing a phenylsulfonyl group

Also Published As

Publication number Publication date
EA008024B1 (ru) 2007-02-27
AU2003253129B2 (en) 2008-12-11
US20080214612A1 (en) 2008-09-04
AU2003253129A1 (en) 2004-02-09
TW200414901A (en) 2004-08-16
WO2004009086A1 (en) 2004-01-29
CO5680445A2 (es) 2006-09-29
ECSP055549A (es) 2005-03-10
NO20050832L (no) 2005-02-16
CN1668303A (zh) 2005-09-14
PL374845A1 (en) 2005-11-14
EP1530470B1 (en) 2009-06-10
CA2490580A1 (en) 2004-01-29
CR7657A (es) 2005-07-13
TWI314860B (en) 2009-09-21
CN1668303B (zh) 2010-10-27
JP2010195820A (ja) 2010-09-09
IL165745A0 (en) 2006-01-15
MY141879A (en) 2010-07-16
EP1530470A1 (en) 2005-05-18
EA200500248A1 (ru) 2005-06-30
HRP20041233A2 (en) 2005-02-28
NZ537138A (en) 2007-11-30
JP5220800B2 (ja) 2013-06-26
ATE433322T1 (de) 2009-06-15
US7399867B2 (en) 2008-07-15
DE60327931D1 (de) 2009-07-23
US20060183736A1 (en) 2006-08-17
BR0312675A (pt) 2005-05-03
JP2005538089A (ja) 2005-12-15
HK1078003A1 (en) 2006-03-03
CA2490580C (en) 2012-12-11
US7585977B2 (en) 2009-09-08
ES2326593T3 (es) 2009-10-15
JP4656939B2 (ja) 2011-03-23
MXPA05000898A (es) 2005-05-16
EP1530470B9 (en) 2010-04-07

Similar Documents

Publication Publication Date Title
PE20040678A1 (es) Moduladores de los receptores selectivos de estrogenos
ATE496620T1 (de) 1h-benzo(f)indazol-5-yl-derivate als selektive glucocorticoid-rezeptor-modulatoren
NO20041504L (no) Lactamderivater som antagonister for humane 11CBY reseptorer.
ATE297910T1 (de) Retinoid x rezeptormodulatoren
TNSN08311A1 (en) Indole sulfonamide modulators of progesterone receptors
EA200970326A1 (ru) Алкильные производные в качестве метаботропных рецепторов глутамата
EA200970811A1 (ru) Новые производные бензамида в качестве модуляторов фолликулостимулирующего гормона
DK1408961T3 (da) 2 pyrrolidon-derivater som prostanoide agonister
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
DE60113032D1 (de) Glucocorticoid Rezeptor Modulatoren
ATE327974T1 (de) Modulatoren des glucocorticoid-rezeptors
BR0104836A (pt) Processo para a preparação de moduladores de receptores de glucocorticóides não-esteroidais
DE60233111D1 (de) Glucocorticoid-rezeptoren-modulatoren
ATE447575T1 (de) Selektive spirocyclische glucocorticoid-rezeptor- modulatoren
ATE448215T1 (de) Selektive östrogen-rezeptor-modulatoren
TW200728274A (en) Cyanopyrrole-phenyl amide progesterone receptor modulators and uses thereof
TW200734302A (en) Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof
DE69917278D1 (de) Heterocyclyl sulphonamid derivate
ATE402140T1 (de) Cyclopentyl sulfonamid derivaten
EA200970189A1 (ru) Пирролидинонанилины как модуляторы прогестероновых рецепторов
NO20044473L (no) Ikke-steroidal progesteron reseptor modulatorer
EP1782810A3 (en) Selective estrogen receptor modulators containing a phenylsulfonyl group

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed